• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Top Stories for the Week of Sept. 4th 2007

Top Stories for the Week of Sept. 4th 2007

September 7, 2007
CenterWatch Staff

Top News

 

Medpace Expands in Eastern Europe with Acquisition

Cincinnati-based contract research organization (CRO) Medpace made its first acquisition with the purchase of Monax, a CRO based in Prague, that it has worked with previously. The deal was a classic partnership turned purchase for the CRO. But the acquisition was a departure from Medpace’s stated organic growth-only philosophy. However, according to Dr. August Troendle, chief executive officer at Medpace, it was a cementing of a working partnership rather than a merger. 

Promedica Forms Alliance with Russian CRO Synergy Research Group

Less than a year ago, Costa Mesa, Calf.-based contract research organization (CRO) Promedica International set out to find a suitable Russian CRO to form an alliance that would expand its geographical reach. Its plan was to tap into the emerging Russian clinical trials market by working with a local company already familiar with the country's clinical research environment. Just about the same time, Moscow-based Synergy Research Group began looking for the same type of partnership: a U.S.-based CRO with a large pool of international clients and the capability of conducting large trials in the West.

Other breaking news...     

  • ClinPhone reduces 2007 revenue forecast...
  • Averion inks deal with BIOCANCER...

Company Profile: An interview with Charles H. Ballow, PharmD, director, Buffalo Clinical Research Center

Upcoming Events

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing